Results 111 to 120 of about 8,500 (184)

A dual-aptazyme system for genetic complementation reveals stage-specific roles for the <i>Trypanosoma cruzi</i> cytoskeleton-associated protein 5.5. [PDF]

mSphere
Wiedeman J, Malli Mohan GB, Seminario-Mondejar G, Etheridge RD.   +3 more
europepmc   +1 more source

Leishmaniasis Incidence and <i>Leishmania</i> Species Distribution in the Apurímac, Ene and Mantaro River Valley, a High-Transmission Endemic Area of Peru. [PDF]

Pathogens
Rivera-Villar J, Rojas-Palomino N, Alarcón-Guerrero J, Cárdenas-López V, Gastelú-Quispe R, Sandoval-Juarez A, Chuchón-Martínez S.   +6 more
europepmc   +1 more source

Effectiveness of harmaline along with meglumine antimoniate on <i>Leishmania major</i>. [PDF]

Vet Res Forum
Ghafourzadeh M, Mirzaie M, Sharifi I, Keyani A, Salarkia E.   +4 more
europepmc   +1 more source

Anti-Leishmania activated C-kinase monoclonal antibody immunohistochemical technique for cutaneous leishmaniasis diagnosis. [PDF]

PLoS One
Santos ADL, Pascoal-Xavier MA, Peruhype-Magalhães V, Eller MTC, Pereira FRV, Rodrigues MP, Brito MNP, E Silva BOS, Silva TRD, Avelar DM, Freire ML, Oliveira E.   +11 more
europepmc   +1 more source

In vitro drug susceptibility of Leishmania donovani from visceral leishmaniasis patients with and without HIV coinfection in Northwestern Ethiopia. [PDF]

Sci Rep
Tufa S, Tadele M, Fikre H, Melkamu R, Yeshanew A, Atnafu S, Mulugeta Z, Kenea D, Kebede B, Hailu A.   +9 more
europepmc   +1 more source

Synthesis and Biological Evaluation of Imidazopyridine-Isatin Hybrids as Inhibitors of <i>Leishmania major</i> Growth. [PDF]

Drug Des Devel Ther
El Hassab MA, Eldehna WM, Elsayed ZM, Elbadawi MM, Negmeldin AT, Balaha M, Nasralla SN, Monir R, Ibrahim TM, Abe M, Tawfik HO, Bekhit AA, Hemeda LR.   +12 more
europepmc   +1 more source

Triazole-Functionalized Jatrophone Derivatives as Antiprotozoal Agents Against <i>Trypanosoma cruzi</i>: Synthesis, Biological Evaluation and Structure-Activity Relationships. [PDF]

Pharmaceuticals (Basel)
Pertino MW, Carreño Gonzalez P, Venegas González C, Schmeda-Hirschmann G, Vega Gómez C, Rolón M, Rojas de Arias A.   +6 more
europepmc   +1 more source

Application of a Microfluidic Lab-on-a-Chip Platform Coupled with Automated Motility Analysis for Phenotypic Drug Screening of <i>Trypanosoma cruzi</i> Trypomastigotes. [PDF]

Sensors (Basel)
Chamorro DA, Cadena Vizuete MF, Layedra G, Isa-Jara R, Giulianotti MA, Pinilla C, Pérez M, Alba Soto CD, Belaunzarán ML, Lerner B, Gimenez G.   +10 more
europepmc   +1 more source

Differential Susceptibility to Antimony in Strains and Clinical Isolates of <i>Leishmania amazonensis</i> from Brazil: In Vitro and In Vivo Studies and Implications for Drug Response and Treatment Failure. [PDF]

Pathogens
de Sousa Agostino V, Geres LF, de la Roca S, de Moraes BT, Aoki JI, Coser EM, Branco N, Coelho AC.   +7 more
europepmc   +1 more source

Ubiquitinome dynamics and regulation by DUB2 during Leishmania differentiation

Antoniou S, Jones NG, Geoghegan V, Dowle A, McNiven C, Neish R, MacDonald C, Wilkinson AJ, Mottram JC.   +8 more
europepmc   +1 more source